David W Woolston
Overview
Explore the profile of David W Woolston including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Woolston D, Lee N, Shadman M, Latorre-Esteves E, Tee X, Fredrickson J, et al.
Haematologica
. 2024 Jul;
109(7):2378.
PMID: 38946649
No abstract available.
2.
Yeung C, Eacker S, Sala-Torra O, Beppu L, Woolston D, Liachko I, et al.
medRxiv
. 2024 Jun;
PMID: 38853970
Background: Cytogenetic analysis encompasses a suite of standard-of-care diagnostic testing methods that is routinely applied in cases of acute myeloid leukemia (AML) to assess chromosomal changes that are clinically relevant...
3.
Pullarkat S, Black G, Bleakley M, Buenrostro D, Chapuis A, Hirayama A, et al.
PLoS One
. 2024 Jun;
19(6):e0303057.
PMID: 38843256
As adoptive cellular therapies become more commonplace in cancer care, there is a growing need to monitor site-specific localization of engineered cells-such as chimeric antigen receptor T (CAR-T) cells and...
4.
Woolston D, Lee N, Shadman M, Latorre-Esteves E, Tee X, Fredrickson J, et al.
Haematologica
. 2023 Sep;
109(3):835-845.
PMID: 37706363
BTK inhibitors, Bcl-2 inhibitors, and other targeted therapies have significantly improved the outcomes of patients with chronic lymphocytic leukemia (CLL). With increased survivorship, monitoring disease and deciphering potential mechanisms of...
5.
Yeung C, Woolston D, Wu V, Voutsinas J, Basom R, Davis C, et al.
Eur J Haematol
. 2023 Aug;
112(1):111-121.
PMID: 37526606
Background: Bone marrow (BM) assessment after CAR-T cell immunotherapy infusion is not routinely performed to monitor adverse events such as cytopenias, hemophagocytic lymphohistiocytosis, or infections. Our institution has performed BM...
6.
Woo J, Choi D, Storer B, Yeung C, Halpern A, Salit R, et al.
Haematologica
. 2019 Jul;
105(3):652-660.
PMID: 31289199
Chronic myelomonocytic leukemia (CMML) is a heterogeneous group of clonal hematopoietic malignancies with variable clinical and molecular features. We analyzed long-term results of allogeneic hematopoietic cell transplantation in patients with...